Changes to the website
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4413

Next 25
Website Changes
04/26/2017 Surgical success in previously “inoperable” brain cancers
04/26/2017 New Tupperware Fundraiser!
04/22/2017 Brains Matter Awareness Fundraiser and Celebration Luncheon / Now Accepting Nomination for our 2017 National Hope Award
04/21/2017 Pediatric Brain Tumor Mutations are Detectable in Cerebrospinal Fluid
04/20/2017 VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigating VB-111 in rGBM
04/19/2017 Effect of gross total resection (GTR) in WHO grade II astrocytomas: A SEER based survival analysis.
04/19/2017 Cloud Over Pediatric Oncologist and Brain Cancer Vaccine
04/18/2017 FDA Okays Clinical Trial of Injectable Brain Cancer Drug - See more at:
04/17/2017 CNS Oncology Publishes Data Suggesting Survival Benefit of Optune™ in Combination with Second Line Chemotherapies after Glioblastoma Recurrence
04/17/2017 Survey on the use of animals in brain cancer research
04/14/2017 Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
04/14/2017 Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
04/12/2017 Feinstein Institute examines use of antiparasitic drug as new treatment for brain tumors
04/09/2017 DFFN: Phase 3 Trial of TSC in GBM to Initiate in 2017
04/07/2017 A Proposed New FDA Drug Approval Pathway: “Conditional Approval”
04/06/2017 Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
04/06/2017 Tocagen wins "Most Successful Early Phase Trial" and "Excellence in Rare Disease Drug Development" awards!
04/06/2017 Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
04/05/2017 Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
04/05/2017 DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting
04/03/2017 "Sci-fi" cancer therapy fights brain tumors, study finds
03/29/2017 MGH/Dana Farber Initiate Expansion of ONC201 Glioblastoma Trial
03/21/2017 VBI Vaccines Building On Duke University Research for New Cancer Therapy
03/20/2017 Is it time for "Conditional Approvals"?

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites